Pregnancy Complication Clinical Trial
Official title:
Effect of Sildenafil Citrate on Uteri- Placental Perfusion, Doppler Indices in Growth Restricted Fetuses
To detect the effect of sildenafil citrate on Doppler parameters in fetuses suffering from growth restriction to support its use later as prolonged therapy in those pregnancies at higher risk for such complication.
Participants were randomized in 1:1 ratio into one of the following drug regime:
Group (I): "sildenafil citrate group" This group consisted of 22 women who received single
oral dose of 50 mg sildenafil citrate.
Group (II): "placebo group" This group consisted of 22 women who received single oral dose
of placebo. All participants were evaluated by ultrasound once they admitted and again after
2-hours following administration of either of the treatment tablets. One sonographer was
allocated to evaluate all mothers included in the study.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03626597 -
Community-based Provision of Urine Pregnancy Tests as Linkage to Reproductive Health Services
|
N/A | |
Enrolling by invitation |
NCT01019785 -
Vitamin D During In Vitro Fertilisation (IVF) - A Prospective Randomized Trial
|
Phase 3 | |
Recruiting |
NCT02372487 -
Sildenafil Citrate Therapy for Oligohydramnios
|
N/A | |
Completed |
NCT00901758 -
Intravenous (IV) Nitroglycerin for Versions in Multiparous Women
|
N/A | |
Recruiting |
NCT06113237 -
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
|
||
Completed |
NCT01762683 -
Influence of Preconceptional Obesity on the Myometrial Cells Differentiation Toward a Contractyl Phenotype
|
N/A |